COHEN RON (President and CEO) purchased 15.6% of their position (20.16K shares) of ACORDA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $12.6K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 3/20/2023ACC: 0001209191-23-020044
DirectorOfficer· President and CEO
Since Sep 2018
+20.16K
Net shares
Net buyer
$12.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
20.16K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10.16K
Price / share
$0.60
Trade value
$6.09K
% of position
7.8%
3/16/2023
129.60K→139.76K
Common Stock
Direct
Shares
+10K
Price / share
$0.65
Trade value
$6.50K
% of position
7.2%
3/17/2023
139.76K→149.76K
Total
Net shares
+20.16K
Net value
$12.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2023 | P · Purchase | +10.16K | $0.60 | $6.09K | 7.8% | 129.60K | 139.76K |
| Common Stock Direct | 3/17/2023 | P · Purchase | +10K | $0.65 | $6.50K | 7.2% | 139.76K | 149.76K |
| Total | +20.16K | $12.59K | ||||||
Derivative Transactions0
No derivative transactions reported